Literature DB >> 11292694

Distribution and kinetics of lipoprotein-bound endotoxin.

J H Levels1, P R Abraham, A van den Ende, S J van Deventer.   

Abstract

Lipopolysaccharide (LPS), the major glycolipid component of gram-negative bacterial outer membranes, is a potent endotoxin responsible for pathophysiological symptoms characteristic of infection. The observation that the majority of LPS is found in association with plasma lipoproteins has prompted the suggestion that sequestering of LPS by lipid particles may form an integral part of a humoral detoxification mechanism. Previous studies on the biological properties of isolated lipoproteins used differential ultracentrifugation to separate the major subclasses. To preserve the integrity of the lipoproteins, we have analyzed the LPS distribution, specificity, binding capacity, and kinetics of binding to lipoproteins in human whole blood or plasma by using high-performance gel permeation chromatography and fluorescent LPS of three different chemotypes. The average distribution of O111:B4, J5, or Re595 LPS in whole blood from 10 human volunteers was 60% (+/-8%) high-density lipoprotein (HDL), 25% (+/-7%) low-density lipoprotein, and 12% (+/-5%) very low density lipoprotein. The saturation capacity of lipoproteins for all three LPS chemotypes was in excess of 200 microg/ml. Kinetic analysis however, revealed a strict chemotype dependence. The binding of Re595 or J5 LPS was essentially complete within 10 min, and subsequent redistribution among the lipoprotein subclasses occurred to attain similar distributions as O111:B4 LPS at 40 min. We conclude that under simulated physiological conditions, the binding of LPS to lipoproteins is highly specific, HDL has the highest binding capacity for LPS, the saturation capacity of lipoproteins for endotoxin far exceeds the LPS concentrations measured in clinical situations, and the kinetics of LPS association with lipoproteins display chemotype-dependent differences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292694      PMCID: PMC98230          DOI: 10.1128/IAI.69.5.2821-2828.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid.

Authors:  M M Wurfel; S D Wright
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

2.  Fast lipoprotein chromatography: new method of analysis for plasma lipoproteins.

Authors:  W März; R Siekmeier; H Scharnagl; U B Seiffert; W Gross
Journal:  Clin Chem       Date:  1993-11       Impact factor: 8.327

Review 3.  Chromatographic techniques for the isolation and purification of lipoproteins.

Authors:  T Tadey; W C Purdy
Journal:  J Chromatogr B Biomed Appl       Date:  1995-09-15

4.  Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin.

Authors:  R I Roth; F C Levin; J Levin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Role for circulating lipoproteins in protection from endotoxin toxicity.

Authors:  K R Feingold; J L Funk; A H Moser; J K Shigenaga; J H Rapp; C Grunfeld
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

6.  Elution of lipoprotein fractions containing apolipoproteins E and A-I in size exclusion on Superose 6 columns is sensitive to mobile phase pH and ionic strength.

Authors:  J Westerlund; Z Yao
Journal:  J Chromatogr A       Date:  1995-12-01       Impact factor: 4.759

7.  Lipoprotein profiling by high performance gel chromatography.

Authors:  G A Tallis; M D Shephard; M J Whiting
Journal:  Clin Chim Acta       Date:  1994-08       Impact factor: 3.786

8.  Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.

Authors:  P S Tobias; K Soldau; J A Gegner; D Mintz; R J Ulevitch
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

9.  Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia.

Authors:  B R Gordon; T S Parker; D M Levine; S D Saal; J C Wang; B J Sloan; P S Barie; A L Rubin
Journal:  Crit Care Med       Date:  1996-04       Impact factor: 7.598

10.  Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.

Authors:  M M Wurfel; S T Kunitake; H Lichenstein; J P Kane; S D Wright
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  51 in total

1.  Diverse range of small peptides associated with high-density lipoprotein.

Authors:  Glen L Hortin; Rong-Fong Shen; Brian M Martin; Alan T Remaley
Journal:  Biochem Biophys Res Commun       Date:  2005-12-27       Impact factor: 3.575

Review 2.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

Review 3.  Endotoxemia-menace, marker, or mistake?

Authors:  Robert S Munford
Journal:  J Leukoc Biol       Date:  2016-07-14       Impact factor: 4.962

Review 4.  Endotoxin elimination in sepsis: physiology and therapeutic application.

Authors:  Klaus Buttenschoen; Peter Radermacher; Hendrik Bracht
Journal:  Langenbecks Arch Surg       Date:  2010-06-27       Impact factor: 3.445

5.  Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density Lipoprotein.

Authors:  Zhili Yao; Jessica M Mates; Alana M Cheplowitz; Lindsay P Hammer; Andrei Maiseyeu; Gary S Phillips; Mark D Wewers; Murugesan V S Rajaram; John M Robinson; Clark L Anderson; Latha P Ganesan
Journal:  J Immunol       Date:  2016-08-17       Impact factor: 5.422

6.  Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial properties.

Authors:  Wendy H J Beck; Christopher P Adams; Ivan M Biglang-Awa; Arti B Patel; Heather Vincent; Eric J Haas-Stapleton; Paul M M Weers
Journal:  Biochim Biophys Acta       Date:  2013-02-26

7.  Effects of dietary supplementation of bentonite and Saccharomyces cerevisiae cell wall on acute-phase protein and liver function in high-producing dairy cows during transition period.

Authors:  Seyed Amin Razavi; Mehrdad Pourjafar; Ali Hajimohammadi; Reza Valizadeh; Abbas Ali Naserian; Richard Laven; Kristina Ruth Mueller
Journal:  Trop Anim Health Prod       Date:  2019-01-30       Impact factor: 1.559

8.  Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins.

Authors:  Sylvette Bas; Richard W James; Cem Gabay
Journal:  BMC Immunol       Date:  2010-09-16       Impact factor: 3.615

Review 9.  The Understanding and Management of Organism Toxicity in Septic Shock.

Authors:  Kelly Roveran Genga; Tadanaga Shimada; John H Boyd; Keith R Walley; James A Russell
Journal:  J Innate Immun       Date:  2018-05-15       Impact factor: 7.349

Review 10.  A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk.

Authors:  J Bruce German; Robert A Gibson; Ronald M Krauss; Paul Nestel; Benoît Lamarche; Wija A van Staveren; Jan M Steijns; Lisette C P G M de Groot; Adam L Lock; Frédéric Destaillats
Journal:  Eur J Nutr       Date:  2009-03-04       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.